BlackRock’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
94,000
-9,000
| -9% | -$197K | ﹤0.01% | 3980 |
|
|
2025
Q1 | $2.3M | Hold |
103,000
| – | – | ﹤0.01% | 3908 |
|
|
2024
Q4 | $2.62M | Buy |
103,000
+8,000
| +8% | +$203K | ﹤0.01% | 3913 |
|
|
2024
Q3 | $2.38M | Hold |
95,000
| – | – | ﹤0.01% | 3897 |
|
|
2024
Q2 | $2.24M | Hold |
95,000
| – | – | ﹤0.01% | 3884 |
|
|
2024
Q1 | $2.43M | Hold |
95,000
| – | – | ﹤0.01% | 3884 |
|
|
2023
Q4 | $2.49M | Sell |
95,000
-50,000
| -34% | -$1.31M | ﹤0.01% | 3876 |
|
|
2023
Q3 | $3.04M | Hold |
145,000
| – | – | ﹤0.01% | 3800 |
|
|
2023
Q2 | $3.52M | Hold |
145,000
| – | – | ﹤0.01% | 3768 |
|
|
2023
Q1 | $3.46M | Sell |
145,000
-5,000
| -3% | -$119K | ﹤0.01% | 3721 |
|
|
2022
Q4 | $3.9M | Hold |
150,000
| – | – | ﹤0.01% | 3776 |
|
|
2022
Q3 | $3.72M | Buy |
+150,000
| New | +$3.72M | ﹤0.01% | 3812 |
|